Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women
Open Access
- 15 June 2009
- journal article
- research article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 181 (1-2) , 55-58
- https://doi.org/10.1503/cmaj.090866
Abstract
A new strain of influenza A virus (novel influenza A H1N1) that originated in swine has rapidly spread from the initial outbreak in Mexico and the southern United States to Canada and many countries in Europe and Asia. Consequently, the World Health Organization raised the level of alert for anThis publication has 22 references indexed in Scilit:
- Limited Inhibitory Effects of Oseltamivir and Zanamivir on Human SialidasesAntimicrobial Agents and Chemotherapy, 2008
- The Metabolism and Transplacental Transfer of Oseltamivir in the Ex Vivo Human ModelInfectious Diseases in Obstetrics and Gynecology, 2008
- Neuraminidase inhibitors for preventing and treating influenza in childrenPublished by Wiley ,2007
- Neuraminidase inhibitors for preventing and treating influenza in healthy adultsPublished by Wiley ,2006
- Maternal influenza during pregnancy and risk of congenital abnormalities in offspringBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Maternal Hyperthermia and the Risk for Neural Tube Defects in OffspringEpidemiology, 2005
- Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemicJournal of Antimicrobial Chemotherapy, 2005
- ACOG Committee Opinion #305: Influenza Vaccination and Treatment During PregnancyObstetrics & Gynecology, 2004
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999
- ZanamivirDrug Safety, 1999